Published: 8 April 2023
Author(s): Jiachen Luo, Zhiqiang Li, Xiaoming Qin, Xingxu Zhang, Xiangdong Liu, Wenming Zhang, Wei Xu, Yiwei Zhang, Yuan Fang, Baoxin Liu, Yidong Wei, NOAFCAMI-SH Registry Investigators
Issue: July 2023
Section: Original article

New-onset atrial fibrillation (NOAF) is a common finding during the acute phase of acute myocardial infarction (AMI) with an incidence rate ranging from 6% to 21% [1]. Although there are numerous studies demonstrating that patients with post-MI NOAF generally have a poor cardiovascular (CV) outcome when compared to those with sinus rhythm [2,3], it is important to realize that the long-term prognosis also can be largely varied across this high-risk population due to differences in patients' comorbidities, medical treatments, as well as AF characteristics [4–6].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.